The clinically important difference on the unified Parkinson's disease rating scale.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Archives of Neurology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1001/archneurol.2009.295PMID 20065131
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Concept of Clinically Meaningful Difference in Health-Related Quality-of-Life Research

  2012cited by this paper
• Determination of the longitudinal validity and minimally important difference of the 8‐item Parkinson's Disease Questionnaire (PDQ‐8)

  2009cited by this paper
• Defining substantial clinical benefit following lumbar spine arthrodesis.

  2008cited by this paper
• Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.

  2008cited by this paper
• Understanding the minimum clinically important difference: a review of concepts and methods.

  2007influential reference
• How well does "evidence-based" medicine help neurologists care for individual patients?

  2007cited by this paper
• Interpreting score differences in the SF-36 Vitality scale: using clinical conditions and functional outcomes to define the minimally important difference

  2007cited by this paper
• Minimal clinically important change on the unified Parkinson's disease rating scale

  2006influential reference
• Defining a minimal clinically relevant difference for the unified Parkinson's rating scale: An important but still unmet need

  2006cited by this paper
• Meaningful Change and Responsiveness in Common Physical Performance Measures in Older Adults

  2006cited by this paper
• Sufficiently Important Difference: Expanding the Framework of Clinical Significance

  2005cited by this paper
• Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches.

  2005influential reference
• Assessing the Minimally Clinically Significant Difference: Scientific Considerations, Challenges and Solutions

  2005cited by this paper
• A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.

  2005cited by this paper
• A clinically meaningful difference was generated for a performance measure of recovery from hip fracture.

  2004cited by this paper
• Levodopa and the progression of Parkinson's disease.

  2004cited by this paper
• A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease.

  2004cited by this paper
• Double‐blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients

  2004cited by this paper
• Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation

  2003cited by this paper
• The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations

  2003cited by this paper
• Clinically important change in quality of life in epilepsy

  2002cited by this paper
• A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study.

  2002cited by this paper
• Methods to explain the clinical significance of health status measures.

  2002cited by this paper
• A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by l-dopa

  2002cited by this paper
• Relation of Distribution- and Anchor-Based Approaches in Interpretation of Changes in Health-Related Quality of Life

  2001cited by this paper
• [The Unified Parkinson's Disease Rating Scale].

  2000cited by this paper
• Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

  2000cited by this paper
• Determining Clinically Important Differences in Health Status Measures

  1999influential reference
• A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson’s disease

  1999cited by this paper
• Ropinirole for the treatment of early Parkinson disease: a 12-month experience. Ropinirole Study Group.

  1998cited by this paper
• Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6‐month interim report of a 3‐year study

  1998cited by this paper
• Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study

  1998cited by this paper
• Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease

  1997cited by this paper
• A comparison of different indices of responsiveness.

  1997cited by this paper
• Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease

  1997cited by this paper
• Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.

  1997cited by this paper
• Assessing the minimal important difference in symptoms: a comparison of two techniques.

  1996cited by this paper
• Patient-Centered Medicine: A Professional Evolution

  1996cited by this paper
• A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.

  1996cited by this paper
• Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study.

  1989cited by this paper
• Measurement of health status. Ascertaining the minimal clinically important difference.

  1989cited by this paper
• Effect of deprenyl on the progression of disability in early Parkinson's disease.

  1989cited by this paper
• Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Projection technique for evaluating surgery in Parkinson’s disease

  1969cited by this paper
• Parkinsonism

  1967cited by this paper

• Medical device-based neuromodulation for motor symptoms in Parkinson's disease: a systematic review and meta-analysis.

  2026cites this paper
• Comment on the article “Traditional Chinese health exercises improve physical function in Parkinson's disease: A systematic review and meta-analysis of randomized controlled trials”

  2026cites this paper
• Reconsidering Placebo Effects in Neuromodulation for Parkinson’s Disease: Lessons for Clinical Trials and Therapeutic Translation

  2026cites this paper
• Real-world data of opicapone in patients with Parkinson's disease experiencing motor fluctuations: the OPTIMO study.

  2026cites this paper
• An explainable ensemble machine learning model using baseline blood transcriptomics to predict Parkinson's disease motor progression.

  2026cites this paper
• Parkinson's disease and voluntary walking interventions - a systematic review and meta-analysis.

  2026cites this paper
• Probiotic, Prebiotic, or Synbiotic Supplementation in Parkinson’s Disease: A Systematic Review and Meta-Analysis with Trial Sequential Analysis

  2026influential citation
• Detailed investigation of the levodopa response rates in distinct motor subscores in Parkinson's disease patients with and without STN-DBS.

  2025cites this paper
• Leukoaraiosis does not impact motor outcomes in Parkinson’s patients post deep brain stimulation

  2025cites this paper
• Moderators of aerobic exercise effects on motor symptoms in patients with Parkinson's disease: A systematic review and meta-analysis.

  2025cites this paper
• Modulating inhibitory synaptic plasticity to restore basal ganglia dynamics in Parkinson's disease

  2025cites this paper
• Investigation of the Impact of Motor, Nonmotor, Cognitive, and Psychometric Features on Freezing of Gait in Parkinson's Disease

  2025cites this paper
• Estimation of and clinical consensus on the meaningful motor progression threshold on MDS-UPDRS Part III

  2025cites this paper
• Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease

  2025influential citation
• Applying Wearable Sensors and Machine Learning to the Diagnostic Challenge of Distinguishing Parkinson’s Disease from Other Forms of Parkinsonism

  2025cites this paper
• InceptoFormer: A Multi-Signal Neural Framework for Parkinson's Disease Severity Evaluation from Gait

  2025cites this paper
• Exploring Non-invasive Brain Stimulation Effects on Physical Outcomes in People With Parkinson’s Disease: An Umbrella Evidence Mapping Review With Meta-analyses

  2025cites this paper
• GLP-1 agonists to slow down Parkinson's progression? The quest continues.

  2025cites this paper
• Effectiveness of Scalp Acupuncture for Parkinson’s Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials

  2025cites this paper
• Neuromodulation in Parkinson’s disease with transcranial pulse stimulation: evidence of clinical efficacy and cortical oscillatory changes

  2025influential citation
• Impact of dance/music and meditation on the progression of Parkinson’s disease with mild/ moderate severity: a single-blinded randomized controlled pilot study

  2025influential citation
• Intraputaminal Delivery of Adeno‐Associated Virus Serotype 2–Glial Cell Line–Derived Neurotrophic Factor in Mild or Moderate Parkinson's Disease

  2025cites this paper
• Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial

  2025cites this paper
• Why “Minimal Clinically Important Difference” for Interpreting the Magnitude of the Treatment Effect Is Not Useful

  2025cites this paper
• Gene therapy for Parkinson's disease: trials and technical advances.

  2025cites this paper
• A mixed methods feasibility study of a ketogenic diet as treatment for Parkinson’s disease

  2025cites this paper
• Performance of 123I‐ioflupane SPECT striatal binding in dementia with Lewy bodies

  2025cites this paper
• Effect of an adapted physical activity program in Parkinson's disease: A randomized controlled study (APA-Park).

  2025cites this paper
• Allogenic transplantation therapy of iPS cell-derived dopamine progenitors for Parkinson's disease -Current status of the Kyoto Trial and future perspectives.

  2025cites this paper
• Longitudinal patterns of loss of independence in Parkinson disease.

  2025cites this paper
• Effects of oral levodopa on motor symptoms and gait impairments in Parkinson’s disease: a systematic review and meta-analysis

  2025influential citation
• A Cross-over Pilot Study on the Effects of Classical Guitar Instruction on Motor and Non-Motor Symptoms in People with Parkinson’s Disease

  2025cites this paper
• Does Pharmacological Adjustment Influence the Outcomes of In-Patient Multimodal Intensive Care? A Study in Patients with Moderately Advanced Parkinson’s Disease

  2025cites this paper
• Analysis of Clinical Characteristics and Rehabilitation Outcomes in Elderly Patients with Parkinson’s Disease: A Retrospective Study

  2025cites this paper
• Accurate Repositioning of Deep Brain Stimulation Electrodes May Preserve Clinical Efficacy

  2025cites this paper
• Plasticity-Induced Motor Recovery of Bilateral Intermittent Theta Burst Stimulation in Parkinson’s Disease: A Randomized, Double-Blind, Sham-Controlled, Crossover Trial

  2025cites this paper
• Preoperative network activity predicts the response to subthalamic DBS for Parkinson's disease

  2025influential citation
• Lower limb motor effects of DBS neurofeedback in Parkinson’s disease assessed through IMU-based UPDRS movement quality metrics

  2025cites this paper
• N-acetylcysteine for Parkinson's disease: a translational systematic review of mechanistic and early clinical data.

  2025cites this paper
• Bi‐Cephalic Self‐Attended Model to Classify Parkinson's Disease Patients With Freezing of Gait

  2025cites this paper
• Comparison of levodopa response rate in association with clinical features in Parkinson's disease subjects with and without STN-DBS.

  2025cites this paper
• Continuous Dopaminergic Stimulation-Based Levodopa Treatment in Patients with Early to Mid-Stage Parkinson’s Disease: A Systematic Review and Meta-Analysis

  2025cites this paper
• Preoperative network activity predicts the response to subthalamic DBS for Parkinson’s disease

  2024cites this paper
• The efficacy and safety of MARS-PD: Meridian activation remedy system for Parkinson’s disease—A single-center, assessor and statistician-blinded, parallel-group randomized, controlled trial protocol

  2024cites this paper
• Liquid Subcutaneous Levodopa-Carbidopa ND0612 Effects on Motor Symptoms in Individuals with Parkinson’s Disease: A Systematic Review and Meta-Analysis

  2024cites this paper
• Immersive Virtual Reality High-Intensity Aerobic Training to Slow Parkinson’s Disease: The ReViPark Program

  2024cites this paper
• Effectiveness and Safety of Meridian Activation Remedy System for Alleviating Motor Symptoms in Parkinson’s Disease: an Observational Study

  2024influential citation
• Short‐Term Cannabidiol with Δ‐9‐Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial

  2024cites this paper
• Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.

  2024cites this paper
• Effects of virtual reality versus motor imagery versus routine physical therapy in patients with parkinson’s disease: a randomized controlled trial

  2024cites this paper
• Bridging the gap between statistical significance and clinical relevance: A systematic review of minimum clinically important difference (MCID) thresholds of scales reported in movement disorders research

  2024cites this paper
• Overcoming Methodological Challenges for Advancing Stem Cell Therapies in Parkinson’s Disease

  2024cites this paper
• Impact of Parkinsonism comorbid depression on cognitive functions

  2024cites this paper
• Causal Forest Machine Learning Analysis of Parkinson’s Disease in Resting-State Functional Magnetic Resonance Imaging

  2024cites this paper
• Estimation of motor severity scales in Parkinson's disease by linear models of bimanual non-alternating index finger tapping features

  2024cites this paper
• Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial

  2024cites this paper
• Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshop

  2024cites this paper
• Long‐Term Follow‐Up of the LEAP Study: Early Versus Delayed Levodopa in Early Parkinson's Disease

  2024cites this paper
• Effects of ankle dorsiflexion training on anticipatory postural adjustments during gait initiation in patients with Parkinson's disease.

  2024cites this paper
• Feasibility of Simon 2-Stage Futility Trials in Early Parkinson Disease

  2024cites this paper
• Effectiveness of robot-assisted training in adults with Parkinson’s disease: a systematic review and meta-analysis

  2024influential citation
• Efficacy and safety of adjunctive oral therapy in Parkinson’s disease with motor complications: a systematic review and network meta-analysis

  2024cites this paper
• A Wearable Gait Monitoring System for 17 Gait Parameters Based on Computer Vision

  2024cites this paper
• Interpersonal Psychotherapy for the Treatment of Depression in Parkinson's Disease: Results of a Randomized Controlled Trial

  2024cites this paper
• Mitteilungen der DGN

  2024cites this paper
• Deep brain stimulation for Parkinson’s disease: systematic review with meta-analysis and trial sequential analysis

  2024cites this paper
• The Development of a Quantitative Disability Assessment Tool in Patients with Idiopathic Parkinson’s Disease

  2024cites this paper
• Brain and muscles magnetic stimulation in a drug-free case of Parkinson’s disease: Motor improvements concomitant to neuroplasticty

  2024influential citation
• Home physical therapy versus telerehabilitation in improving motor function and quality of life in Parkinson’s disease: a randomized controlled trial

  2024influential citation
• Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease

  2024cites this paper
• High-Intensity Interval vs. Moderate-Intensity Continuous Training in Parkinson's Disease: A Randomized Trial.

  2024cites this paper
• Linking Invasive and Noninvasive Brain Stimulation in Parkinson's Disease: A Randomized Trial

  2024cites this paper
• Utilizing Entropy of Cadence to Optimize Cycling Rehabilitation in Individuals With Parkinson’s Disease

  2024cites this paper
• Modulation of inhibitory synaptic plasticity for restoration of basal ganglia dynamics in Parkinson's disease

  2024cites this paper
• Feasibility Study of Parkinson’s Speech Disorder Evaluation With Pre-Trained Deep Learning Model for Speech-to-Text Analysis

  2024influential citation
• Intravenous arachnoid granulation hypertrophy in patients with Parkinson disease

  2024cites this paper
• Optimizing rehabilitation strategies in Parkinson’s disease: a comparison of dual cognitive-walking treadmill training and single treadmill training

  2024influential citation
• Classification of Cell Therapy Products by Cell Manipulation Degree and Functions Performed: Analysis of International Regulatory Approaches

  2024cites this paper
• Objective clinical registration of tremor, bradykinesia, and rigidity during awake stereotactic neurosurgery: a scoping review

  2024cites this paper
• Simplification of Mobility Tests and Data Processing to Increase Applicability of Wearable Sensors as Diagnostic Tools for Parkinson’s Disease

  2024cites this paper
• The Feasibility and Efficacy of a Virtual Reality Tandem Cycling Program for Persons with Parkinson’s Disease and Their Care Partners

  2024influential citation
• Assessing Changes in Motor Function and Mobility in Individuals with Parkinson’s Disease After 12 Sessions of Patient-Specific Adaptive Dynamic Cycling

  2024cites this paper
• Safinamide as an Adjunct to Levodopa in Asian and Caucasian Patients With Parkinson’s Disease and Motor Fluctuations: A Post Hoc Analysis of the SETTLE Study

  2023cites this paper
• Exercise effects on motor function, manual dexterity, and brain oscillatory activity in individuals with Parkinson's disease: Randomized controlled trial protocol.

  2023cites this paper
• A Randomized Placebo-Controlled Study of a Transcranial Photobiomodulation Helmet in Parkinson’s Disease: Post-Hoc Analysis of Motor Outcomes

  2023cites this paper
• Effect of Physiotherapy Interventions on Motor Symptoms in People With Parkinson’s Disease: A Systematic Review and Meta-Analysis

  2023cites this paper
• Defining Clinical Meaningfulness in Huntington's Disease

  2023cites this paper
• How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson’s disease?

  2023cites this paper
• Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.

  2023cites this paper
• Quality of life and functional limitations in persons with epilepsy.

  2023cites this paper
• The effect of cardiovascular risk on disease progression in de novo Parkinson's disease patients: An observational analysis

  2023cites this paper
• Amount and Distribution of Intracranial Calcification in Symptomatic and Asymptomatic Primary Familial Brain Calcification

  2023cites this paper
• Computer vision quantification of whole-body Parkinsonian bradykinesia using a large multi-site population

  2023cites this paper
• The effects of safinamide according to gender in Chinese parkinsonian patients

  2023cites this paper
• A Randomized Phase 3 Study Comparing P2B001 to its Components (Low‐Dose Extended‐Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended‐Release Pramipexole in Early Parkinson's Disease

  2023influential citation
• The effects of an individualized smartphone-based exercise program on self-defined motor tasks in Parkinson’s disease: a long-term feasibility study

  2023influential citation
• The Effects of Safinamide in Chinese and Non-Chinese Patients with Parkinson’s Disease

  2023cites this paper
• Side of motor symptom onset predicts sustained Attention deficits and motor improvements after Attention training in Parkinson's disease.

  2023cites this paper
• Efficacy of non-immersive virtual reality-based telerehabilitation on postural stability in Parkinson’s disease: a multicenter randomized controlled trial

  2023cites this paper
• Directional versus ring-mode deep brain stimulation for Parkinson’s disease: protocol of a multi-centre double-blind randomised crossover trial

  2023cites this paper